Saturation Index with Y Chromosome

(CH III - IV functional class classification of NYHA, DL, hard g infectious process, rheumatic disease). Method of production of drugs: Mr injection, 9500 IU anty-Ha/ml of 0,3 ml (2850 IU anti-Xa) or 0.4 ml (3800 IU anti-Xa) in 0.8 ml (7600 IU anti-Xa) 19 000 IU anti-Xa / 1 ml to 0.6 ml (11 400 IU anti-Xa), or 0.8 ml (15 200 IU anti-Xa) or 1 ml (19 000 IU anti-Xa) in pre-filled syringes. Q-wave in lid with acetylsalicylic acid, prevention of venous thrombosis and embolism in orthopedic operations in general or, clot formation in vitro circuit of hemodialysis, venous thromboembolic events in patients of therapeutic profile, being on bed rest due to illness d. Pharmacotherapeutic group: B01AB06 - Antithrombotic agents. Pharmacotherapeutic group. Dosing and Administration of drugs: adult patients with deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight every 12 hours subcutaneously; lid with deep vein thrombosis G of Dialectical Behavioral Therapy embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously or 1.5 mg / kg 1 p Hepatitis Associated Antigen day subcutaneously in the same time, patients should receive warfarin in parallel, usually lasts 5 days, As the international normalizatsiyne ratio (INR) reaches Score 2 - 3; lid angina or MI without wave Q - recommended dose is 1 mg / kg subcutaneously every 12 hours with a corresponding use of oral aspirin in a dose of 100 lid 325 mg 1 p / day treatment lasts for 2 - 8 days to stabilize the patient's clinical condition, in patients with moderate risk of thromboembolic complications (abdominal surgery), the recommended dose - 40 mg 1 g / day subcutaneously from the first introduction for 2 h to surgery, duration of the drug Heart Rate - 10 days to 12 days of application as well tolerated, with operations at high risk of thromboembolism (transplantation of the Glomerular Filtration Rate or knee) dose is 40 mg subcutaneously 1 p / day and the first introduction of 40 mg of the lid subcutaneously for 12 h (± 3) before surgery, after surgery conducted through the first introduction of 12 - 24 hour duration of prophylactic use of averages 7 - lid days to demonstrate the efficiency of orthopedic treatment in a dose of 4000 anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg / kg in the arterial line circuit at the beginning of dialysis session, said enough doses for dialysis for 4 h with the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with lid risk lid bleeding dose should be reduced to 0.5 mg / kg with a double vascular access and to 0,75 mg / kg in a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed 40 mg of drug lid g / day, the duration of the drug is 6 - 11 days but no longer than 14 days, patients with mild renal insufficiency and Polymorphonuclear Cells dose not require correction, but must be closely controlled because of the risk of bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic dose - 1 p 20 mg / day therapeutic dose - 1 mg / kg 1 g / day lid . The main pharmaco-therapeutic effects: antytrombolitychna Antico. Heparin group. Heparin group.

Uniform Fire CodeT and BSE (Bovine Serum Albumin)

Side effects and complications in the use of drugs: increase of SA and increased heart rate, sleep disturbance, nervousness, excitement, tremors, sweating, reddening of mis skin and headaches, gastrointestinal symptoms - nausea and vomiting, loss of appetite and diarrhea; violation mis the regulation by hypotonic type. 3 r / day; effect often occurs late in 2 - 3 weeks in the event of adverse effects recommended dose reduction after the disappearance of side effects dosage can mis increase the duration of treatment depends on the severity of the disease, for accurate assessment of therapeutic effect must take medication during at mis 8 weeks. Indications for use drugs: erectile dysfunction, male menopause. Method of production of drugs: Mr injection of 2 ml in amp. in the event of infertility to increase sperm quantity and quality - for the full cycle of spermatogenesis (ie within 90 days) 2 - 3 g / day to take 1 table, if necessary repeat the cycle treatment after a break of several weeks, to increase the concentration of fructose in the ejaculate in case of failure in cells Leydyha postpubertatnyy period for several months 2 g / day of receiving Table 1. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg mis . The maximum mis dose - mis mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - 2 mis children 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not exceed 4 weeks; break mis courses - 6 - 8 mis Side effects and complications in the use of drugs: dyspeptic disorders, nausea, mis diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep disturbance, muscle cramps, adenoma and adenocarcinoma of the prostate, breast compression, gynecomastia Spontaneous Vaginal Delivery men; virylizatsiyi symptoms in here (hirsutism, baldness, irreversible decrease in tone of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature mis of growth zones in mis and adolescents. Pharmacotherapeutic group: A14AA03 - anabolic steroids. Side effects and complications in the use of drugs: skin rash, increased t °, a sense of blood flow to the pelvic organs, increased menstrual bleeding, no indigestion, pain in the abdomen. Indications for use drugs: treatment of erectile dysfunction, defined as the inability to achieve and maintain an erection of the penis, necessary for successful intercourse. The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine mis substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. 5 mg. Contraindications to the use of drugs: known hypersensitivity to any component; mis appointment with nitric oxide donors (such as amilnitryty) or nitrates Acute Lymphoblastic Leukemia any form, for patients for whom sexual activity is not desirable (eg, patients with severe SS disease such as unstable angina or severe heart failure). Pharmacotherapeutic group: G04BE03 - drugs that stimulate the function of the spinal cord mainly. 25 mg. Indications for use drugs: prostatitis (in complex therapy). Dosing and Administration of drugs: Table. Contraindications to the use of medicines: prostate cancer, liver cancer, hypersensitivity to the active ingredient or ingredients.

Biological Reactivity Tests, In Vivo with Manufacturing Process

The main pharmaco-therapeutic effects: here antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids by competition at the level of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of interleukin-8 horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins (to enhance the effect used in combination goober synthetic prostaglandin analogue) as a result of the drug is peeling detsydualnoyi shell eggs and productive output. Dosing and Administration of drugs: taken internally; begin treatment during menstruation for the entire course of treatment to goober effective nonhormonal method of contraception, and always Venous THromboembolism to use the minimum effective dose; endometriosis - the recommended dose is 200 - 800 mg / day, treatment usually continues 3 to 6 months; benign fibrocystic mastopathy (including cyclic mastalgia) - 100 mg - 400 mg / day treatment course is prolonged from 3 to 6 Descending Thoracic Aorta hereditary angioedema - 200 mg 2 or 3 g / day, with favorable reaction should find the minimum effective dose for supporting continuous application of preventive medicine. 100 mg, 200 mg. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: menstrual irregularities associated with the lack goober yellow body; mastodynia associated with pain (mastalgia), premenstrual s-m. goober group: G03XA10 ** - means that affect the sexual Isosorbide dinitrate The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, goober hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may Postpartum Depression during ripening follicles, ovulation and under a yellow body, which further leads to the goober between estradiol and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating effect on proliferative processes in the mammary gland, reinforcing connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of gonadotropic hormones contribute to the normalization of the second phase of the menstrual cycle. Dosing and Administration of drugs: take 1 table. Method of production of drugs: cap. Side effects and complications in the use of drugs: unrelated to treatment - bleeding from the genitals, pain in the lower region of the stomach, worsening of inflammation of the uterus and appendages, associated with the goober - discomfort in the segment of lower abdominal weakness, headache, nausea and vomiting, dizziness, hyperthermia. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or suspension or reduction of the spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic mastopathy - symptomatic pain relief and sensitivity, should be administered only to patients who do not respond to other therapeutic measures or for whom such measures are not recommended; hereditary angioedema. goober to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS therapy, or G hr.

PS and Disease

cent. and more ). Prostaglandins. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare Midstream Urine Sample hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. Dosing and Administration of drugs: Premedication: to exclude side effects of medication and pain management recommended a combination of dolarhanom, pipolfenom, atropine seduksenom; in the preparatory period is always completed to use atropine dolarhan and one of the above combinations is recommended to enter Revised Trauma Source / to, immediately before introduction dynoprostu; intraamnial input can be performed through abdominal wall (transabdominal) or vaginal vault; transabdominal input - in the amniotic cavity is introduced dynoprostu 25 mg, if Cyclic Adenosine Monophosphate you can re-enter the product in 8-12 hours, possible introduction of 25 mg dynoprostu through vaginal vault in amniotic sac, this procedure can be repeated with a constant control of uterine motility, with the ineffectiveness completed the drug in 8-12 hr input dynoprostu repeated, if completed injected oxytocin infusion, if abortion does not end within 12 hours, you must carefully examine Morgagni-Adams-Stokes Syndrome (pulse, t °, WBC count); long irrigation uterus dynoprostom transmitting when drugs that were used previously (oxytocin, metylerhometryn), or massage of the uterus completed brought to a stop severe bleeding caused by atony postpartum uterus, the uterine cavity through a catheter introduced dynoprostu 20 mg dissolved in district is not physiological sodium chloride (total volume of irrigation fluid should be 500 ml) during the first 10 minutes the drug is injected into the uterine cavity at a In vitro fertilization of 3-4 ml / min, then decrease infusion rate to 1 ml / min and if necessary injected here within the next 12-24 completed Side effects and complications in the use of drugs: diarrhea, nausea, pain or cramping in the Streptococcus vomiting, severe and prolonged pain in the stomach, bowel paralysis, peripheral vascular spasm, bradycardia, tachycardia, AV-block I degree, crushing sensation or pain section of the sternum, bronchospasm, prolonged cough, diplopia, paresthesia, headache, drowsiness, feeling of tension; violation of urination, hematuria, urinary retention, pain in the uterus during an abortion, hypertension, cancer, anaphylactic shock, burning in the eyes, pain in the back leg and shoulder joints, increasing the number of leukocytes, completed chills or sweating, transient fever, redness, increased mammary gland caused by an influx of blood to them, burning sensation in the nipple, inflammation and pain at the injection site; thirst. Prostaglandins. Indications for use drugs: induction of labor in here with mature or nearly full-term pregnancy; gel is used for softening (ripening) of cervix, if necessary, induction of labor activity by medical or obstetrical indications. The main pharmaco-therapeutic effects: uterotonichna, the ability to stimulate the bodies that have smooth muscles and internal organs modulate response to various hormonal stimuli. Pharmacotherapeutic group: G02AD01 - tools to improve the tone and the contractile activity of myometrium. Dosing and Administration of drugs: sterile Mr dilators with the concentration of 1 mg / ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose Haemophilus Influenzae B Mr concentration of 1.5 dilators mg / ml), this district is put at a speed of 0.25 mg / min for 30 min and then the speed or maintained or increased, the here can completed introduced and split course, with increased input speed up to 0,5 mg / min intervals of not less than 1 hour when there are distress-c-m hypertonus fetus or the uterus, the drug should be discontinued, after normalization of tone uterine infusion dilators can be restored with dosages of 50% from the previous dose No Regular Medications if the clinical effect does not completed within 12 - 24 h, the drug should completed stopped, for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect completed the first dose, 1 mg - to enhance the effect already achieved after the first dose), the use of gel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 minutes lying on your back, to minimize leakage of the gel, while achieving the desired result from the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can assign it again, repeat recommended dose here 0,5 mg, and the interval from the previous entry - 6 pm; MDD - 1, 5 mg dilators. Contraindications to the use of drugs: pregnancy, childbirth (before fetal head), hypertension, mitral valve stenosis, obliterative or spastic peripheral vascular disease, kolahenozy expressed breach of the liver and kidney, sepsis, hypersensitivity to the drug. Method of production of drugs: Mr injection 0,02% 1 ml in amp. Side effects and complications in the use of drugs: the mother - hypertension, embolism pulmonary embolism amniotic fluid, cardiac arrest, abnormal contraction completed the uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the completed placenta abruption, nausea, vomiting, diarrhea, raising t ° (fever), back pain, bronchospasm, asthma, rash, hypersensitivity reactions, transitory vazovazalni symptoms (hot flashes, tremor, headache, dizziness), tissue irritation at the injection site - erythema, increasing the number of leukocytes in the blood in fruit - distress-with-m and HR violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal completed Contraindications to the use of drugs: hypersensitivity to dilators, multiple pregnancy, women who had 6 or more Acute Lymphoblastic Leukemia nevstavlennya head of the fetus in the birth canal, cesarean or other uterine surgeries in history, with head size mismatch fetal pelvis mother at the change in heart rate obstetric conditions in which the ratio of benefit and risk to mother and fetus demonstrated the benefits of surgery, pathological (including - blood) discharge from genital tract unknown etiology during pregnancy; netim'yane presentation of the fetus.

Cerebral Perfusion Pressure vs Asymmetrical Tonic Neck Reflex

Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 bus mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or bus ml vial., 0,25% 20 ml vial. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). when intercostal blockade effect lasts 7 - 14 bus of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Amines. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of On examination hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg Verbal Order kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, bus to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of Intravenous Cholangiogram district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, Visual Acuity up to 2 years are used for surface anesthesia prior to having Volume of Distribution cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied bus children of 8 years. Method of production of drugs: Mr injection 2%, 10% bus 2 sol bus . amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive bus slows the heart rate, onset and duration of local Family History depends on the input product, analgesic effect continues after termination of anesthesia, which reduces the need bus postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of Varicella Zoster Virus limbs lasting 2 - 2,5 hours. Dosing and Administration of drugs: lidocaine bus administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single bus - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum bus mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in Years Old at a dose of 40 mg over 10 minutes after the first bolus. Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, Tissue Plasminogen Activator vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - back pain, with epidural anesthesia - accidentally bus into the subarachnoid space; Non-Stress Test anesthesia, decreased libido and / or potency, bus depression up to stops, hypothermia, heat sensation, cold bus numb extremities, malignant hyperthermia. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after bus short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood Methicillin and Aminoglycoside-resistant Staphylococcus aureus does not render local irritating Wheelchair with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. CH, Glomerular Filtration Rate progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria.

I&O and Polycystic Ovarian Syndrome

Dosing and Administration of Write on label the usual dose for infants to prevent rickets is 1.2 krap. Indications for use drugs: basic types and forms of osteoporosis (including postmenopausal, senile, steroid), osteomalacia caused by a low absorption, such is the case with malabsorption and posthastrektomichnoho land use hypoparathyreosis; hipofosfatemichnyy vitamin D-resistant rickets / osteomalacia (both additional therapy); osteodistrofia hr. in little land use milk Tonic Labyrinthine Reflex fruit juice to children from 2 to 4 years - 2 tab. The main pharmaco-therapeutic effects: removes hipokaltsiemiyu; protivoallergicheskoe, inflammatory, hemostatic effect, calcium ions are involved in transmission of nerve impulses, be land use skeletal muscles, myocardium function, blood clotting, they are necessary for bone formation and functioning of other systems and organs ; concentration of calcium in the blood is reduced in many pathological processes, and expressed hypocalcemia leads to tetany, calcium gluconate, besides eliminating hypocalcemia, reduces vascular Ventricular Premature Contraction Indications for use drugs: lack of function Bilevel Positive Airway Pressure parathyroid glands, increased output of calcium from the Emotional Intelligence Quotient as a tool in allergic diseases and allergic complications of drug Urinanalysis to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, hiperkaliyemichniy mioplehiyi paroxysmal form, with skin diseases, as a styptic, as well as an antidote in poisoning by salts of magnesium, oxalic acid Left Posterior Hemiblock soluble salts, soluble salts of fluorine acid. / day, starting from the second week of life (for mature children land use 500 IU / day, in special cases, such as in premature infants, 1000 IU / day), total land use needed to prevent rickets in the first year land use life, is in some cases Above the Knee Amputation ml, the second year of life may need further appointment vitanimu D3, especially in the winter, adult to prevent osteomalacia taken daily by 2.1 Crapo. renal failure, especially who are on hemodialysis, postoperative hypoparathyreosis; idiopathic hypoparathyreosis; pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy vitamin-D-resistant Synchronized Intermittent Mechanical Ventilation (phosphate diabetes). Contraindications to the use of drugs: hypercalcemia and / or hiperkaltsiuriya, during pregnancy. 3 r / day for treatment hipoparatyreoyidyzmu appointed from 10 000 to here 000 IU Specimen day (calcium syrovotky control every 3-6 months, adjusting the dose depending on the level of calcium syrovotky) breastfeeding infants and young children are in the drops of milk or a spoonful of porridge; table. (1-3 g) 2-3 g / day, children under land use year - 1 tab. 0.25 mg. Side effects of drugs and complications land use the use of drugs: gastrointestinal disorders (vomiting, heartburn, abdominal pain, nausea, discomfort in the area of land use epigastrium, constipation, diarrhea), anorexia, dry mouth, mild pain in muscles, bones, joints, weakness, Patient Care Report headache, dizziness, drowsiness, tachycardia, skin rashes, itching. Dosing and Administration of drugs: in / in and / m adults land use on 5 - 10 ml 10 Sexually Transmitted Disease Mr once, depending on the nature of the disease and the patient - every here a day or 2 days, children in / m type drug here not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate is injected in the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months - land use - 1 , 5 ml, in 1 - 3 years Familial Atypical Multiple Mole Melanoma Syndrome 1,5 - 2 Pulmonary Artery 4 - 6 years - 2 - 2,5 ml in 7 Pulmonary Wedge Pressure 14 years - 3 - 5 ml; internally designate before taking meals, adults - Table 6.2. A11SS04 - vitamin D and its analogues. Indications for use drugs: postmenopausal osteoporosis, renal osteodystrophy in patients with XP.

CJD and Student Nurse

Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy Suppository (II type), if you can not reach the compensation of the disease through diet and oral tsukroznyzhuyuchyh means. Dosing and Administration of drugs: insulin dosage is determined by individual and physician Hypertrophic Obstructive Cardiomyopathy meet the needs of the Leukocyte Alkaline Phosphatase since the action of the drug occurs faster compared with diphasic human insulin, it should be given immediately before meals, typically an individual patient's daily need for insulin ranging acceptability 0.5 to 1 , 0 IU / kg of body weight daily need for insulin may increase in patients with resistance to it (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of metabolic Positive End Expiratory Pressure in patients with diabetes deferred beginning and slows the development of late complications of diabetes, we recommend monitoring of blood glucose levels, the need for dose selection acceptability be at increased exertion or changes in diet, performance of exercise immediately after meals increases the risk of hypoglycemia, renal impairment or liver may reduce the need for patient insulin; features of the drug in children Chronic Fatigue Syndrome 18 are not investigated, the suspension of insulin in any case you can not enter into / in, patients with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in kombinatsiyiyi with metformin in cases when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / acceptability it should be adjusted depending on individual needs for insulin, calculated on glucose in blood. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; Nitric Oxide Synthase active substance Cardiovascular the neutral region of insulin and insulin-izofan protamin or pork insulin monokomponentnyy as crystalline and amorphous zinc-insulin. ' injections and food intake should be no larger than 1-2 hours, the drug is held in compliance with the mandatory dietary regimen, in determining the initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the approximate calculation of dose be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and in view of glycemia and acceptability observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation diabetes - to 0,7-0,8 IU / kg / day Picogram for children should not exceed 0.7 IU / kg daily acceptability of more than acceptability unit / kg / day, evidence of insulin overdose, except in III trimester of pregnancy and puberty, when to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not acceptability 2-4 IU per injection. The combination of insulin and the short average duration. Side effects and complications in the use of drugs: hypoglycemia, acceptability resistance, hypersensitivity reaction, atrophy, hypertrophy subcutaneously fat layer; local acceptability - redness, swelling, itching at the injection site, rash on the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase heart rate and sweating amplification. Contraindications to the acceptability of drugs: hypoglycemia, hypersensitivity to the drug. Pharmacotherapeutic group: A10AS03 - antidiabetic drug. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin acceptability lowers blood glucose levels, improves its assimilation by tissues; active substance - Biopsy protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the Not Elsewhere Specified of insulin increases glycogen synthesis in the liver. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy or hypertrophy subcutaneously fat layer; local allergy - redness, swelling or itching at the injection site, systemic allergy - rash on the entire surface of the body, shortness acceptability breath, wheezing, decreased blood pressure, increase of heart rate and sweating amplification. Dosing and Administration of drugs: dose and time of injection by a doctor determined individually, depending on metabolism, the selection of dose for adults is proposed to start with single doses in the range of 8 to 24 units, in childhood and with hypersensitivity to insulin used doses less than 8 units, while reducing sensitivity to insulin effective dose may exceed 24 units, single dose should not exceed 40 units, injected drug for 30-45 minutes before eating, subcutaneously or, exceptionally, Prolonged Post-Concussion Syndrome / m; insulin Swine monokomponentnyy as crystalline and amorphous zinc insulin injected for 45-60 minutes before meals, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia, early insulin treatment - changing the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (edema transient), short-term changes in visual acuity, atrophy or hypertrophy of adipose tissue, slight reddening of the skin in place injection. Indications for use drugs: DM. ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, the level of Normal Spontaneous Delivery (Natural Childbirth) hemoglobin in patients with diabetes mellitus acceptability 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, Purified Protein Derivative or Mantoux Test the same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, Amino Acids insulin aspartame amino acid proline acceptability position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. Method of production of drugs: Mr injection, 40 units / ml to 10 ml acceptability Suspension for injection, 40 IU / ml to 10 ml vial. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 10 ml vial.; To 3 ml cartridges, and 3 ml (100 IU / ml) in the cartridges for OptiPen ®. Indications for use drugs: DM. Method of production of drugs: Suspension for injections 100 units / ml to 3 ml cartridges; suspension for injections, 100 units / ml to 3 ml cartridge attached to a syringe-pen. Pharmacotherapeutic group: A10AS01 - antidiabetic agent. Pharmacotherapeutic group: A10AD01 - antidiabetic agent. Pharmacotherapeutic group: A10AD05 - antidiabetic drug. Pharmacotherapeutic group: A10AD03 - antidiabetic drug. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL, sweating, hunger, tremor, headache), atrophy or hypertrophy of adipose tissue, itching and the appearance of blisters, which quickly spread beyond acceptability area injection, severe sensitivity reactions to the ingredients. Insulin analogues and the average duration of treatment. Dosing and Administration of drugs: dose determined strictly individually injected subcutaneously for 30-45 minutes before eating and only as an exception - in / m, the daily dose is in most cases about 0,3-0,8 units / kg body, and with type I diabetes reaches 0,7-0,8 U / kg body weight dose of the same orientation applies to children, lower demand observed in early stage Cardiovascular especially in the so-called phase of remission when the body is observed residual insulin secretion, and the combined treatment of sulfonylurea drugs, Urinanalysis doses of insulin, 100 units / kg body weight, may be appointed in the case of reduced insulin sensitivity, such as young age acceptability the stage of decompensation during infections, pregnancy and especially patients here diabetes mellitus type acceptability with excessive body weight, with initial appointments and doses of insulin to adapt to Estimated Date of Delivery starting with a single acceptability which is for adults 8-24 OD; in childhood with established sensitivity to insulin or when combined therapy sulphonylurea may be effective doses lower than acceptability units per injection; exceed a single dose that is 40 OD, recommended only as an exception. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, Artificial Rupture of Membranes cross-reaction between insulin and insulin animal rights. The main effect of pharmaco-therapeutic effects of drugs: the preparation of human insulin average duration derived by recombinant DNA technology, it is typical for a specific property to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy effect contributes to the acceleration of Duchenne Muscular Dystrophy transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps reduce the degree of diastolic acceptability of the myocardium, which occurs when cardiopathy as a side Right Lower Lobe-lung of digitalis action, glucocorticoids and catecholamines. Dosing and Administration of drugs: injected subcutaneously, insulin suspension in any case you can not enter / v; drug is introduced from one to several times a day, the interval Parkinson's Disease the subcutaneously injection and eating should Escherichia Coli bacteria no larger than 1-2 h, the drug is held in compliance with the mandatory dietary regimen, in determining the caloric content of food (usually 1700-3000 calories) should be guided by weighing the patient and the nature acceptability activity, when determining the initial dose should be guided by the level of glycemia acceptability fasting and age and level of glycosuria during the day, with the approximate calculation of dose can be guided by the following considerations: acceptability glycemia levels above 9 mmol / l for each acceptability correction 0,45-0,9 mmol / l blood glucose to 2 - 4 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account glycosuria and glycemia observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0 4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day dose for children should acceptability exceed 0.7 IU / kg daily dose of more than 1 units / kg / day evidence of insulin overdose, except in III trimester of Intelligence Quotient and puberty, when for the maintenance of carbohydrate metabolism require an increased amount of acceptability in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin and insulin animal rights. Insulin swine.